| ORIGINAL ARTICLE |
|
| Year : 2013 | Volume
: 5
| Issue : 3 | Page : 115-117 |
|
|
Proliferating trichilemmal cyst: The value of ki67 immunostaining
Lucia Rangel-Gamboa1, Magdalena Reyes-Castro2, Judith Dominguez-Cherit3, Elisa Vega-Memije1
1 Division of Investigation, General Hospital "Dr. Manuel Gea González", Calz. Tlalpan 4800, Seccion VX, C.P 14000, Mexico
2 Department of Pathology, General Hospital "Dr. Manuel Gea González", Calz. Tlalpan 4800, Seccion VX, C.P 14000, Mexico
3 Department of Dermatology, INCMN "Salvador Zubirán", Vasco de Quiroga 15, Sección XVI, 14000, Mexico City, Mexico
Correspondence Address:
Lucia Rangel-Gamboa
Division of Investigation, General Hospital "Dr. Manuel Gea Gonzalez", Calz. Tlalpan 4800, Seccion VX, C.P 14000, Mexico City
Mexico
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-7753.125599
|
|
|
Background: A proliferating trichilemmal cyst (PTC) is an uncommon, rapidly-reproducing cutaneous epithelial cyst, differentiating from the isthmic portion of the outer hair root sheath. It is usually described as a benign tumor, but malignant transformation has been reported and is then denominated as a malignant proliferating trichilemmal tumor. Ki67 immunostaining has been used as a methodology for the evaluation of tumor grade in other tumors, due to its distinctive reaction patterns which exclusively involve proliferating cells. Objectives: (1) To report the incidence of cases of PTCs in a General Hospital during a 12 years period. (2) To determine the expression of ki67 using immunohistochemical staining. (3) To correlate ki67 reaction patterns with clinical prognosis. Materials and Methods: The dermatology department's files during a period of 12 years were reviewed; cases with a diagnosis of PTC were selected, and ki67 immunostaining was done when enough biological material was available. Results: A total of 15 cases with a diagnosis of PTC were identified. In 12 cases, ki67 immunostaining was carried out. In 9 of the 12 cases, ki67 was observed in the basal cells of the cystic epithelium, one case was moderately positive in palisading epithelial cells; in the other two cases ki67 immunostaining was negative. Clinical follow-up was done and revealed that no patient had local recurrence in 5 years after surgical removal of PTC. We therefore consider this immunostaining technique is probably correlated with low recurrence potential. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
